Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study

Blood. 2001 Nov 15;98(10):3174-5. doi: 10.1182/blood.v98.10.3174.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Bone Marrow Transplantation*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects*
  • Cyclosporine / therapeutic use
  • Disease-Free Survival
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Leukemia / epidemiology
  • Leukemia / therapy*
  • Life Tables
  • Middle Aged
  • Recurrence
  • Risk
  • Transplantation, Homologous

Substances

  • Immunosuppressive Agents
  • Cyclosporine